| 摘要 |
<p>Homoarginine-based peptides of formula (I), where R, R1 and R2 are defined in the specification are compounds having warm-blooded platelet aggregation inhibition drug properties, e.g., N-[N-[N-[N6-(aminoiminomethyl)-N2-glycyl-L-lysyl]glycyl]-1-α-aspartyl]-L-serine, or which are chemical intermediates to such drug compounds.</p> |
